Heres a breakdown of the dosing and findings from this trial [12]: The participants in the three groups (cagrilintide + semaglutide, semaglutide alone, and cagrilintide alone) followed a dosing regimen that involved increasing the dosage every four weeks, starting from 0.25 mg and moving up to 0.5 mg, 1.0 mg, and 1.7 mg until reaching the final dose of 2.4 mg/week at the 16-week mark
When to reduce dose or stop Reduce your dose if side effects are persistent (lasting more than a few days), interfere with daily activities, or worsen rather than improve over time
Ongoing monitoring
Neurobion injections are used for improving nerve health, vitamin B deficiencies, and for symptoms such as fatigue, weakness, feelings of numbness, or tingling that are caused by a neuropathy or a metabolic disorder
People with certain health conditions including HIV, alcohol use disorder, and Crohns disease may not absorb vitamin B effectively